The S207 sites within the ketoacyl-synt domain of FASN showed significant difference phosphorylation levels in tumor tissue compared to normal tissue (Figure 15B–15D, Figure 15F–15H, all P < 0.05), followed by the T2204 sites between PP-binding and thioesterase domain for colon cancer (Figure 15B, P = 5.8e-10), UCEC (Figure 15C, P = 8.0e-04) and breast cancer (Figure 15E, P = 1.9e-03). This evidence concerns the gene FASN and breast cancer.